Naong, Kailyn .
HRN: 27-80-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/15/2025
09/22/2025
IV
54mg
Q24h
Neonatal Pneumonia
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines